Literature DB >> 15921643

[Toxic Epidermal Necrolysis (Lyell syndrome): a pathology for burn units].

Luis Cabral1, Carla Diogo, Filipe Riobom, Luis Teles, Celso Cruzeiro.   

Abstract

Toxic Epidermal Necrolysis (Lyell's syndrome) is a rare but very serious dermatological lesion, characterized by the sudden onset of high fever, signs of systemic toxicity and intense mucocutaneous exfoliation. Its pathophysiology is not yet well determined, although it is almost consensual the presence of an immunological basis. It appears usually as an answer to the taking of a given drug, and, in spite of being self-limited in the absence of complications, if not well managed it is associated with great morbidity and a high mortality, due, in most cases, to the developing of sepsis. Treatment includes mainly the immediate suspension of the inducing drug and the precocious admission of the patient in a hospital facility with the capacity to provide intensive support care and to minimize the infectious risk, having also the conditions for the execution of surgical debridement and covering of the affected areas, that is to say in Burn Units. There are in study several therapeutical measures designed to lower the morbidity and mortality of this syndrome, namely the use of plasmapheresis; the administration of high doses of N-acetylcysteine; immunosuppression; hyperbaric oxygen, etc. The authors present the treatment protocol in use at the Coimbra Burns Unit, in Portugal, illustrated with a clinical case from that Unit.

Entities:  

Mesh:

Year:  2004        PMID: 15921643

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  4 in total

1.  Don't live in a town where there are no doctors: toxic epidermal necrolysis initially misdiagnosed as oral thrush.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Mohamad Ibrahim Fatani; Khaled Shawkat Ali; Amer Mohd Khoujah; Mubeena Akhtar; Ghassan Adnan Al Maimani; Sadeya Hanif Raja; Ashraf Basraheel; Khurram Fareed
Journal:  BMJ Case Rep       Date:  2009-12-30

2.  Therapeutic approach of Lyell syndrome with infliximab and dexamethasone pulse: report of a clinical case.

Authors:  Jânia Dara Jácome Pacheco; Maria Rodrigues Viegas Ribeiro; Catarina Sousa Duque Soares Queirós; Maria Fátima Cameira Martins Xambre
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

3.  Lyell's Syndrome and Antimalarials: A Case Report and Clinical Review.

Authors:  Joana Miranda Nunes; Sofia Santareno; Lina Guerreiro; Ana Filipa Margalho
Journal:  J Glob Infect Dis       Date:  2017 Jan-Mar

4.  Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.

Authors:  Luana Bernardes Arantes; Carmélia Santiago Reis; Alice Garbi Novaes; Marta Rodrigues de Carvalho; Leila Bernarda Donato Göttems; Maria Rita Carvalho Garbi Novaes
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.